Medreich Limited — Fluoxetine Exporter Profile
Indian Pharmaceutical Exporter · #11 for Fluoxetine · $2.2M export value · DGFT Verified
Medreich Limited is the #11 Indian exporter of Fluoxetine with $2.2M in export value and 126 verified shipments. Medreich Limited holds a 0.9% market share in Fluoxetine exports across 2 countries. The company exports 42 pharmaceutical products worth $224.8M across 15 therapeutic categories.
Medreich Limited — Fluoxetine Export Profile: Buyers & Destinations
Where Does Medreich Limited Export Fluoxetine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $2.1M | 125 | 98.9% |
| PORTUGAL | $23.5K | 1 | 1.1% |
Medreich Limited exports Fluoxetine to 2 countries. The largest destination is UNITED KINGDOM accounting for 98.9% of Medreich Limited's Fluoxetine shipments. These destinations reflect Medreich Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fluoxetine from Medreich Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MEDREICH PLC | UNITED KINGDOM | $2.1M | 125 |
| LABORATORIOS BASI | PORTUGAL | $23.5K | 1 |
Medreich Limited supplies Fluoxetine to 2 buyers globally. The largest buyer is MEDREICH PLC (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fluoxetine Export Value and How Much Does Medreich Limited Contribute?
India exported $59.0M worth of Fluoxetine through 3,702 shipments from 253 suppliers to 101 countries, serving 522 buyers globally. Medreich Limited contributes $2.2M to this total, accounting for 0.9% of India's Fluoxetine exports. Medreich Limited ships Fluoxetine to 2 countries through 2 buyers.
What Is the Average Shipment Value for Medreich Limited's Fluoxetine Exports?
Medreich Limited's average Fluoxetine shipment value is $17.5K per consignment, based on 126 shipments totaling $2.2M. The largest destination is UNITED KINGDOM (98.9% of Medreich Limited's Fluoxetine exports).
How Does Medreich Limited Compare to Other Indian Fluoxetine Exporters?
Medreich Limited ranks #11 among 253 Indian Fluoxetine exporters with a 0.9% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($10.9M), MICRO LABS LIMITED ($7.7M), ALEMBIC PHARMACEUTICALS LIMITED ($5.8M). Medreich Limited processed 126 shipments to 2 destination countries.
What Fluoxetine Formulations Does Medreich Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FLUOXETINE HYDROCHLORIDE 20MG HARD CAPSU | $169.0K | 4 |
| FLUOXETINE 20MG CAPSULES 3X10S (969 | $83.5K | 2 |
| FLUOXETINE 20MG CAPSULES 3X10S (966 | $68.7K | 3 |
| FLUOXETINE 20MG CAPSULES 3X10S 195465 PACKS | $50.0K | 1 |
| FLUOXETINE 20MG CAPSULES 3X10S (195465 PACKS) | $50.0K | 1 |
| FLUOXETINE 60MG CAPSULES 3X10S (320 | $48.5K | 3 |
| FLUOXETINE 20MG CAPSULES 3X10S (194 | $46.2K | 1 |
| FLUOXETINE 20MG CAPSULES 3X10S (97095PACKS) | $43.8K | 1 |
| FLUOXETINE 20MG CAPSULES 3X10S (96567PACKS) | $43.5K | 1 |
| FLUOXETINE HYDRCHLORIDE 20MG HARD CAPSULES (FLUOXETINE 20MG CAPSULES,HARD) KEY PHARMA 3X10S (97491 PACKS) | $43.2K | 1 |
Medreich Limited exports 93 distinct Fluoxetine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FLUOXETINE HYDROCHLORIDE 20MG HARD CAPSU with 4 shipments worth $169.0K.
Regulatory Requirements: Exporting Fluoxetine to Key Markets
What Medreich Limited must comply with to export Fluoxetine to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medreich Limited Compare to Nearest Fluoxetine Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | APL HEALTHCARE LIMITED | $3.6M | 73 | 1 | $48.9K |
| 10 | CIPLA LIMITED | $3.0M | 92 | 4 | $32.5K |
| 11 | MEDREICH LIMITED ★ | $2.2M | 126 | 2 | $17.5K |
| 5 | TORRENT PHARMACEUTICALS LTD | $1.9M | 39 | 2 | $50.0K |
| 15 | AUROBINDO PHARMA LIMITED | $1.3M | 55 | 6 | $23.2K |
Medreich Limited ranks #11 among 253 Indian Fluoxetine exporters. Average shipment value of $17.5K compared to the market average of $233.1K. The closest competitors by value are APL HEALTHCARE LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Fluoxetine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 603 | 16.3% |
| SAHAR AIR | 508 | 13.7% |
| NHAVA SHEVA SEA (INNSA1) | 285 | 7.7% |
| MUNDRA SEA | 150 | 4.1% |
| MUNDRA SEA (INMUN1) | 129 | 3.5% |
| Bombay Air | 119 | 3.2% |
| DELHI AIR | 110 | 3.0% |
| HYDERABAD ICD (INSNF6) | 108 | 2.9% |
What Other CNS & Psychiatric Products Does Medreich Limited Export?
Medreich Limited also exports these cns & psychiatric products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medreich Limited's Fluoxetine Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medreich Limited. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased shipping costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structures of exporters relying on these routes. (sgeexport.com)
Conversely, the US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of tariffs on pharmaceutical imports by the US poses a risk to Indian companies, as higher tariffs could render low-margin generic drugs unprofitable, leading to market exits and exacerbating drug shortages in the US. (cfo.economictimes.indiatimes.com)
The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a favorable development for Medreich. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, providing immediate cost relief and enhancing market access. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, creating new opportunities for companies like Medreich to expand their presence in the EU market. (en.wikipedia.org)
Medreich Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements that companies must adhere to for market access. Recent regulatory frameworks have increased compliance costs by an average of 18.7%, leading to a 15.2% reduction in export volumes to the US in the first quarter of 2025. (transdatanexus.com)
For Medreich Limited, maintaining compliance with these evolving standards is crucial to sustaining and expanding its export markets. Investments in quality assurance, regular audits, and staying abreast of regulatory changes are essential strategies to navigate this complex landscape.
About Medreich Limited
Medreich Limited exports 42 products worth $224.8M. Beyond Fluoxetine, top products include Amoxicillin, Potassium, Flucloxacillin, Rosuvastatin, Atorvastatin. View the complete Medreich Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fluoxetine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fluoxetine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medreich Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 126 individual customs records matching Medreich Limited exporting Fluoxetine, covering 93 formulations to 2 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 101+ countries, 522+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fluoxetine Export Data from Medreich Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medreich Limited's Fluoxetine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medreich Limited
Full Company Profile →
42 products · $224.8M total trade · 15 categories
Fluoxetine Stats
Company Overview
Top Products by Medreich Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medreich Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluoxetine. For current shipment-level data, contact TransData Nexus.